Loading…
Based on limited metadata, the FDA issued a Warning Letter to CBD Online Store on April 7, 2020, regarding products classified as drugs. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information, though FDA Warning Letters typically address unauthorized drug claims, manufacturing defects, or regulatory compliance failures. The letter falls under FDA's drug regulatory authority, though the specific issuing office is unknown. To understand the precise violations and required corrective actions, the complete Warning Letter would need to be reviewed.